IP Verse

Celator Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Celator Pharmaceuticals opposed by its competitors

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3300601
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
EP2768484
Jul 24, 2019Lyophilized Liposomes2
EP2120568
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2

Latest publications and patents of Celator Pharmaceuticals New

Explore the latest publications and patents granted to Celator Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Celator Pharmaceuticals

EP3300601
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative DisordersGranted And Under Opposition
EP2768484
Jul 24, 2019Lyophilized LiposomesRevoked
EP2120568
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative DisordersRevoked

Latest PTAB cases involving Celator Pharmaceuticals

Discover the latest PTAB cases involving Celator Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Celator Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CELATOR PHARMACEUTICALS - 7 - -
D YOUNG29 - - -
GENERICS UK214 - - -
SANDOZ1181619 -